Does DOCETAXEL\DOCETAXEL ANHYDROUS Cause Disease progression? 289 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 289 reports of Disease progression have been filed in association with DOCETAXEL\DOCETAXEL ANHYDROUS. This represents 7.6% of all adverse event reports for DOCETAXEL\DOCETAXEL ANHYDROUS.
289
Reports of Disease progression with DOCETAXEL\DOCETAXEL ANHYDROUS
7.6%
of all DOCETAXEL\DOCETAXEL ANHYDROUS reports
65
Deaths
46
Hospitalizations
How Dangerous Is Disease progression From DOCETAXEL\DOCETAXEL ANHYDROUS?
Of the 289 reports, 65 (22.5%) resulted in death, 46 (15.9%) required hospitalization, and 19 (6.6%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOCETAXEL\DOCETAXEL ANHYDROUS. However, 289 reports have been filed with the FAERS database.
What Other Side Effects Does DOCETAXEL\DOCETAXEL ANHYDROUS Cause?
Diarrhoea (409)
Myelosuppression (404)
Off label use (281)
Nausea (279)
Neutropenia (250)
Fatigue (236)
Pyrexia (221)
Vomiting (216)
Asthenia (190)
Anaemia (188)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which DOCETAXEL\DOCETAXEL ANHYDROUS Alternatives Have Lower Disease progression Risk?
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCONEXENT\ICOSAPENT\PHOSPHATIDYL SERINE
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCOSANOL
DOCETAXEL\DOCETAXEL ANHYDROUS vs DOCUSATE